Insider Transactions in Q3 2024 at Lexaria Bioscience Corp. (LEXX)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 12
2024
|
Catherine C. Turkel Director |
BUY
Open market or private purchase
|
Direct |
1,600
+34.04%
|
$4,800
$3.13 P/Share
|
Jul 31
2024
|
Vanessa Carle Secretary |
SELL
Open market or private sale
|
Direct |
2,567
-100.0%
|
$10,268
$4.0 P/Share
|